CD4 and neoplasm: Next, we conditionally knocked Ltbr into CD4+ T cells (Ltbr-cKI) and assessed its anti-tumor effects, finding that these CD4+ T cells inhibited tumor growth (Fig. 1A–D) and improved prognosis (Fig. 1E).